NVX-144

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNVX-144
Drug Alias NameEIF2AK3 kinase modulator (Novelix)NVX-144
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 modulators
TargetsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southern California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovelix PharmaceuticalsUniversity Of Southern California
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A